StonvexLoading…
StonvexCore line items from SYY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Annual 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $62.43B | $41.91B | $21.15B | $81.37B |
Operating Income | $2.11B | $1.49B | $800.00M | $3.09B |
Net Income | $1.21B | $866.00M | $476.00M | $1.83B |
EPS (Diluted) | $2.51 | $1.80 | $0.99 | $3.73 |
Total Assets | $27.98B | $27.18B | $27.04B | $26.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.90B | $1.22B | $844.00M | $1.07B |
Free Cash Flow OCF − CapEx | $1.00B | $311.00M | $-74.00M | $1.60B |
Shares Outstanding | 480.74M | 480.51M | 480.37M | 489.83M |